Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 1, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
8-K Dec 16, 2021 FORM 8-K
4 Dec 3, 2021 OWNERSHIP DOCUMENT
4 Dec 3, 2021 OWNERSHIP DOCUMENT
4 Dec 3, 2021 OWNERSHIP DOCUMENT
4/A Dec 3, 2021 OWNERSHIP DOCUMENT
4/A Dec 3, 2021 OWNERSHIP DOCUMENT
4/A Dec 3, 2021 OWNERSHIP DOCUMENT
8-K Nov 12, 2021 8-K
10-Q Nov 12, 2021 10-Q
8-K Sep 24, 2021 FORM 8-K
S-8 Aug 13, 2021 FORM S-8
8-K Aug 12, 2021 8-K
10-Q Aug 12, 2021 10-Q
8-K Jul 7, 2021 FORM 8-K
8-K/A Jun 14, 2021 FORM 8-K/A
8-K Jun 9, 2021 FORM 8-K
DEFA14A Jun 4, 2021 DEFA14A
8-K Jun 4, 2021 FORM 8-K
8-K Jun 2, 2021 FORM 8-K
← Newer Page 9 of 51 · 1272 filings Older →